Chris Pasquale

Stock Analyst at Guggenheim

(0.35)

# 4,309

Out of 5,131 analysts

3

Total ratings

n/a

Success rate

-9.93%

Average return

Main Sectors:

Top Industries:

Medical Devices Medical Instruments & Supplies

Stocks Rated by Chris Pasquale

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	DXCM DexCom	Upgrades: Buy	$145	$67.40	+115.13%	1	Jan 7, 2022
	COO The Cooper Companies	Upgrades: Buy	$124	$83.45	+48.29%	1	Jan 3, 2022
	PRCT PROCEPT BioRobotics	Initiates: Buy	$45	$32.83	+37.07%	1	Oct 11, 2021

DexCom

Jan 7, 2022

Upgrades: Buy

Price Target: $145

Current: $67.40

Upside: +115.13%

The Cooper Companies

Jan 3, 2022

Upgrades: Buy

Price Target: $124

Current: $83.45

Upside: +48.29%

PROCEPT BioRobotics

Oct 11, 2021

Initiates: Buy

Price Target: $45

Current: $32.83

Upside: +37.07%